Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Capricor Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 56 | 61 | +5 |
| Shares | 4.82M | 6.43M | +1.61M (+33.4%) |
| Value | $32.7M | $30.7M | −$2.06M (−6.3%) |
New holders (22)
Institutions that held Capricor Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 89,314 | $426.0K | 0.00% |
| Oppenheimer & Co Inc | 54,646 | $260.7K | 0.00% |
| Nuveen Asset Management, LLC | 34,320 | $163.7K | 0.00% |
| Rhumbline Advisers | 30,886 | $147.3K | 0.00% |
| Gsa Capital Partners LLP | 27,330 | $130.0K | 0.01% |
| Alpine Global Management, LLC | 24,168 | $115.3K | 0.02% |
| Squarepoint Ops LLC | 22,695 | $108.3K | 0.00% |
| New York State Common Retirement Fund | 21,600 | $103.0K | 0.00% |
| Trexquant Investment LP | 18,879 | $90.1K | 0.00% |
| Barclays PLC | 17,572 | $83.8K | 0.00% |
| Corebridge Financial, Inc. | 13,656 | $65.3K | 0.00% |
| Engineers Gate Manager LP | 13,419 | $64.0K | 0.00% |
| Invesco Ltd. | 12,134 | $57.9K | 0.00% |
| Group One Trading, L.P. | 11,695 | $55.8K | 0.00% |
| Activest Wealth Management | 10,000 | $47.7K | 0.02% |
| Legal & General Group Plc | 2,725 | $13.0K | 0.00% |
| Ameritas Investment Partners, Inc. | 2,487 | $11.9K | 0.00% |
| California State Teachers Retirement System | 1,839 | $8.77K | 0.00% |
| Amalgamated Bank | 878 | $4.00K | 0.00% |
| Signaturefd, LLC | 393 | $1.88K | 0.00% |
| New Millennium Group LLC | 59 | $281 | 0.00% |
| Northwestern Mutual Wealth Management Co | 19 | $91 | 0.00% |
Sold out (17)
Institutions that held Capricor Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Arrowstreet Capital, Limited Partnership | 101,542 | $689.0K |
| HRT Financial LP | 82,557 | $560.0K |
| Wellington Management Group LLP | 79,759 | $541.6K |
| Cubist Systematic Strategies, LLC | 54,268 | $368.5K |
| Walleye Capital LLC | 47,646 | $323.5K |
| ExodusPoint Capital Management, LP | 24,570 | $167.0K |
| Point72 Asia (Singapore) Pte. Ltd. | 23,678 | $160.8K |
| Y-Intercept (Hong Kong) Ltd | 19,537 | $132.7K |
| Brevan Howard Capital Management LP | 19,468 | $132.2K |
| Omers Administration Corp | 18,000 | $122.2K |
| Balyasny Asset Management LLC | 12,994 | $88.2K |
| Woodline Partners LP | 12,461 | $84.6K |
| Jefferies Financial Group Inc. | 10,600 | $72.0K |
| Prudential Financial Inc | 10,000 | $67.9K |
| Federated Hermes, Inc. | 68 | $462 |
| FMR LLC | 1 | $7 |
| Macquarie Group Ltd | 941 | $6 |